IMI impact on data - Event

Start Date 09/06/2021 End Date 09/06/2021
Online, Virtual Event

About this event


MI has had ‘big data’ projects since its creation.  What’s more, the projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease, haematological malignancies (blood cancers), Alzheimer’s disease, and prostate cancer. IMI also boasts a number of projects working on health-related mobile and digital technologies.


IMI is organising a series of  live sessions on IMI Impact, where key actors will explore the challenges and demonstrate how IMI contributed. During these sessions, we will also share patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.

Furthermore, we hope to engage IMI stakeholders in a broader discussion on IMI’s impact and ask them for their active participation in these live events. With this initiative, we aim to demonstrate the successful IMI model of radical collaboration.


Therefore, we invite you to register via the link below! 


For more information on about IMI Impact on data go here! 




Click here to register

Registration for this event is free but obligatory.


For any questions about this event please contact Rui Ribeiro at


Draft agenda



Welcome and introduction

by Colm Carroll, Scientific Project Manager, IMI


What was the state of play before IMI # The challenge

by Dr Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi



How IMI projects have addressed the challenge & 'moved the needle' # Solutions from IMI projects


Dr Mats Sundgren, Director Health Informatics, AstraZeneca

Dr Jennifer Lane, Versus Arthritis Clinical Research Fellow in Trauma and Orthopaedic Surgery, University of Oxford

Prof. Dr. med. Lars Bullinger, Director of the Department of Haematology, Oncology and Tumourimmunology, Charité Universitätsmedizin Berlin


Q&A Time



Closing remarks

by Colm Carroll, Scientific Project Manager, IMI


Meet the speakers


Speaker pic_Terttu Haring Speaker pic_Mats Sundgren Speaker pic_Jennifer Lane Speaker pic_Lars Bullinger

Dr Terttu Haring

Global Head for

Clinical Digital Innovation


Dr Mats Sundgren

Director Health Informatics


Dr Jennifer Lane

Versus Arthritis Clinical Research

Fellow in Trauma

and Orthopaedic Surgery

University of Oxford  

Prof. Dr. med. Lars Bullinger

Director of the Department of Haematology,

Oncology and Tumourimmunology, 

Charité Universitätsmedizin Berlin, Berlin

Moderated by:

Speaker pic_Colm Carroll

Colm Carroll 

Scientific Project Manager, IMI